Table 1.
Inclusion criteria.
| Population | People susceptible for developing COVID-19 |
| Intervention | All policy measures/strategies related to protection, detection, containment/prevention, or treatment of COVID-19 |
| Comparators | Doing nothing or alternative policy measures/strategies to protect, detect, contain/prevent, or treat COVID-19 |
| Outcomes | All outcomes related to cost-effectiveness, cost-utility, and cost-benefit analyses whereby a comparative analysis of alternative strategies is conducted in terms of both costs and effects |
| Context | COVID-19 pandemic |
| Study design | Trial-based or model-based health economic evaluations or systematic reviews reporting on health economic evaluations |
| Evidence | Only peer-reviewed publications |
| Language | English, French, or Dutch |
COVID-19 indicates coronavirus disease 2019.